Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
Kelly S. Chien, Christine B. Peterson, Elliana Young, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5691-5697
Open Access | Times Cited: 10

Showing 10 citing articles:

Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre–Cellular Therapy SARS-CoV-2 Infection
Ila Nimgaonkar, Leah H Yoke, Pavitra Roychoudhury, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 86-95
Closed Access | Times Cited: 9
Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study
Makoto Saito, Akio Mori, Takashi Ishio, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 328-328
Open Access | Times Cited: 2
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 5103-5115
Open Access | Times Cited: 5
The Outcome of SARS-CoV-2 Infection in Patients with Lymphoma and the Risk Factors for the Development of Pneumonia
Hanter Hong, Su‐Mi Choi, Yeong-woo Jeon, et al.
Infection and Chemotherapy (2024) Vol. 56, Iss. 3, pp. 378-378
Open Access | Times Cited: 1
Perspectives and Challenges of COVID-19 with Obesity-Related Cancers
Μaria Dalamaga, Narjes Nasiri‐Ansari, Nikolaos Spyrou
Cancers (2023) Vol. 15, Iss. 6, pp. 1771-1771
Open Access | Times Cited: 2
Inactivated Vaccine Dosage and Serum IgG Levels Correlate with Persistent COVID-19 Infection in Hematologic Malignancy Patients During the Omicron Surge in China
Ye Li, Ye Yang, Xuewu Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Effectiveness of Paxlovid in the treatment of the SARS-CoV-2 Omicron variant infection in children with hematologic malignancies: a retrospective cohort study
Xiaoxia Deng, Yuelian Jiang, Wenjuan Chen, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 8, pp. 4219-4230
Open Access
Outcomes and Patterns of Evolution of Patients with Hematological Malignancies during the COVID-19 Pandemic: A Nationwide Study (2020–2022)
Rafael García Carretero, María Ordoñez-Garcia, Ruth Gil-Prieto, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5400-5400
Open Access
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China
Ye Li, Ye Yang, Xuewu Zhang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality
Shlomzion Aumann, Uria Tsubary, Boaz Nachmias, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 1, pp. 135-145
Open Access | Times Cited: 1
Page 1

Scroll to top